News

Filter

1 to 9 of 96178 results

FTC approves final order on Akorn divestment in bid for VersaPharm

21-09-2014

Following a public comment period, the US Federal Trade Commission has approved a final order settling…

AkornAntibiotics and Infectious diseasesGenericsLegalMergers & AcquisitionsRifampinUSAVersaPharm

Diabetes becomes a global challenge at EASD, as hypoglycaemia has severe economic impact

Diabetes becomes a global challenge at EASD, as hypoglycaemia has severe economic impact

19-09-2014

Here's our take on the week's top stories.

DiabetesEuropeHealthcareNovo NordiskPharmaceutical

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

Vifor appoints Dario Eklund head of international business and Abdul Mullick head of global marketing

19-09-2014

Swiss-based iron deficiency specialist Vifor Pharma has appointed Dario Eklund as head of international…

BoardroomHematologyPharmaceuticalSwitzerlandVifor Pharma

Biotie receives final European milestone from Lundbeck on Selincro French launch

Biotie receives final European milestone from Lundbeck on Selincro French launch

19-09-2014

Danish CNS drug specialist Lundbeck has brought Selincro (nalmefene) on the market in France. Selincro,…

BiotechnologyBiotie TherapiesFinlandFranceLicensingLundbeckNeurologicalSelincro

EyeForPharma Multichannel Marketing Summit 2014:

EyeForPharma Multichannel Marketing Summit 2014: "Your desk is the worst place from which to view the world"

19-09-2014

One of the key messages from the EyeForPharma Multichannel Marketing Summit in London yesterday was that…

Health Medical PharmaLEO PharmaMarkets & MarketingPharmaceuticalPharmacologySanofiUK

EXPERT VIEW: The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

EXPERT VIEW: The Interim Exec Community calls for a ‘Conscious Coupling’ of RPOs and Interims Specialists

19-09-2014

Pharmaceutical companies have widely adopted strategies to outsource elements of their business operations,…

BoardroomGlobalInterviewsPharmaceuticalRecruitment

Report shows Eylea and Lucentis are equally likely to be covered by payers

Report shows Eylea and Lucentis are equally likely to be covered by payers

19-09-2014

Recently launched anti-vascular endothelial growth factor (VEGF) agent Eylea (aflibercept), from USA-based…

EyleaFinancialGenentechLucentisOphthalmicsPharmaceuticalRegeneron PharmaceuticalsUSA

European Commission approves Gilead’s Zydelig for blood cancer

European Commission approves Gilead’s Zydelig for blood cancer

19-09-2014

The European Commission has granted marketing authorization for US biotech major Gilead Sciences’ Zydelig…

BiotechnologyEuropeGilead SciencesLymphomaMedicineOncologyRegulationZydelig

1 to 9 of 96178 results

Back to top